133 related articles for article (PubMed ID: 7511552)
21. Monitoring of hepatocellular carcinoma, following proton radiotherapy, with contrast-enhanced color Doppler ultrasonography.
Niizawa G; Ikegami T; Matsuzaki Y; Saida Y; Tohno E; Kurosawa T; Saito Y; Chiba T; Kita Y; Tokuuye K; Akine Y; Tanaka N
J Gastroenterol; 2005 Mar; 40(3):283-90. PubMed ID: 15830288
[TBL] [Abstract][Full Text] [Related]
22. Repeated proton beam therapy for hepatocellular carcinoma.
Hashimoto T; Tokuuye K; Fukumitsu N; Igaki H; Hata M; Kagei K; Sugahara S; Ohara K; Matsuzaki Y; Akine Y
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):196-202. PubMed ID: 16563656
[TBL] [Abstract][Full Text] [Related]
23. Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract.
Nakayama H; Sugahara S; Fukuda K; Abei M; Shoda J; Sakurai H; Tsuboi K; Matsuzaki Y; Tokuuye K
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):992-5. PubMed ID: 21543162
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
[TBL] [Abstract][Full Text] [Related]
25. Proton beam therapy for hepatocellular carcinoma.
Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
[TBL] [Abstract][Full Text] [Related]
26. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
[TBL] [Abstract][Full Text] [Related]
27. Proton beam therapy for hepatocellular carcinoma with inferior vena cava tumor thrombus: report of three cases.
Mizumoto M; Tokuuye K; Sugahara S; Hata M; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Tohno E; Akine Y
Jpn J Clin Oncol; 2007 Jun; 37(6):459-62. PubMed ID: 17553815
[TBL] [Abstract][Full Text] [Related]
28. The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial.
Bush DA; Kayali Z; Grove R; Slater JD
Cancer; 2011 Jul; 117(13):3053-9. PubMed ID: 21264826
[TBL] [Abstract][Full Text] [Related]
29. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis.
Mizumoto M; Tokuuye K; Sugahara S; Nakayama H; Fukumitsu N; Ohara K; Abei M; Shoda J; Tohno E; Minami M
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):462-7. PubMed ID: 18243571
[TBL] [Abstract][Full Text] [Related]
30. The usefulness of radiation therapy for hepatocellular carcinoma.
Matsuura M; Nakajima N; Arai K; Ito K
Hepatogastroenterology; 1998; 45(21):791-6. PubMed ID: 9684136
[TBL] [Abstract][Full Text] [Related]
31. The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study.
Wada Y; Takami Y; Matsushima H; Tateishi M; Ryu T; Yoshitomi M; Matsumura T; Saitsu H
Intern Med; 2018 May; 57(10):1345-1353. PubMed ID: 29279513
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities.
Lim DH; Lee H; Park HC; Lee JA; Kim SW; Yoo BC; Koh KC; Lee JH; Choi MS; Gwak GY; Paik SW
Am J Clin Oncol; 2013 Apr; 36(2):162-6. PubMed ID: 22391433
[TBL] [Abstract][Full Text] [Related]
33. Impact of Proton Beam Irradiation of an Anatomic Subsegment of the Liver for Hepatocellular Carcinoma.
Hojo H; Raturi V; Nakamura N; Arahira S; Akita T; Mitsunaga S; Nakamura M; Motegi A; Kageyama SI; Zenda S; Okumura M; Ikeda M; Akimoto T
Pract Radiat Oncol; 2020; 10(4):e264-e271. PubMed ID: 31585204
[TBL] [Abstract][Full Text] [Related]
34. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial.
Bush DA; Hillebrand DJ; Slater JM; Slater JD
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S189-93. PubMed ID: 15508084
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma.
Park J; Jung J; Kim D; Jung IH; Park JH; Kim JH; Lee SW; Yoon SM
BMC Cancer; 2018 Oct; 18(1):1040. PubMed ID: 30367606
[TBL] [Abstract][Full Text] [Related]
36. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
37. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of publications on charged particle therapy for hepatocellular carcinoma.
Igaki H; Mizumoto M; Okumura T; Hasegawa K; Kokudo N; Sakurai H
Int J Clin Oncol; 2018 Jun; 23(3):423-433. PubMed ID: 28871342
[TBL] [Abstract][Full Text] [Related]
39. Surgical spacer placement and proton radiotherapy for unresectable hepatocellular carcinoma.
Komatsu S; Hori Y; Fukumoto T; Murakami M; Hishikawa Y; Ku Y
World J Gastroenterol; 2010 Apr; 16(14):1800-3. PubMed ID: 20380016
[TBL] [Abstract][Full Text] [Related]
40. Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma.
Furuse J; Ishii H; Nagase M; Kawashima M; Ogino T; Yoshino M
J Gastroenterol Hepatol; 2005 Oct; 20(10):1512-8. PubMed ID: 16174067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
